Inflammation Characteristics | Unused(N = 703) | piperacillin-tazobactam + vancomycin (N = 396) | p |
---|---|---|---|
platelet (median [IQR]) | 215.00 [162.50, 278.00] | 232.50 [170.00, 321.50] | 0.001 |
po2 (median [IQR]) | 125.00 [81.00, 225.50] | 101.00 [72.75, 174.75] | < 0.001 |
pco2 (median [IQR]) | 40.00 [35.00, 47.00] | 42.00 [36.00, 51.25] | 0.016 |
wbc (median [IQR]) | 9.90 [7.40, 13.30] | 12.20 [8.30, 17.20] | < 0.001 |
rbc (median [IQR]) | 4.10 [3.47, 4.58] | 3.85 [3.21, 4.46] | 0.002 |
lymphocytes (median [IQR]) | 11.60 [6.95, 19.30] | 7.95 [5.00, 13.20] | < 0.001 |
monocytes (median [IQR]) | 5.40 [3.85, 7.65] | 4.40 [3.00, 6.40] | < 0.001 |
neutrophils (median [IQR]) | 80.10 [71.25, 86.45] | 84.45 [76.68, 88.23] | < 0.001 |
basophils (median [IQR]) | 0.30 [0.20, 0.50] | 0.20 [0.00, 0.40] | < 0.001 |
eosinophils (median [IQR]) | 0.60 [0.10, 1.50] | 0.20 [0.00, 0.90] | < 0.001 |